Guangdong, China

Hui Ouyang

This inventor holds 1 USPTO granted patent. Top assignee: Smilebiotek Zhuhai Limited. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hui Ouyang. Retrieved from https://idiyas.com/inventor/hui-ouyang-w0tcipi7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hui Ouyang: Innovator in Intraocular Disease Treatment

Introduction

Hui Ouyang is a notable inventor based in Guangdong, China. He has made significant contributions to the field of intraocular diseases, particularly through his innovative patent that addresses age-related macular degeneration (AMD). His work is crucial in the ongoing search for effective treatments for eye diseases.

Latest Patents

Hui Ouyang holds a patent for "Animal models, screening methods, and treatment methods for intraocular diseases or disorders." This patent provides screening methods and animal models related to intraocular diseases such as AMD. It aims to identify candidate therapeutics for treating or preventing eye diseases. The patent also includes compounds and compositions that are useful for killing or inhibiting the growth of microorganisms, which are essential in treating infections associated with such diseases.

Career Highlights

Hui Ouyang is currently associated with Smilebiotek Zhuhai Limited, where he applies his expertise in developing innovative solutions for eye health. His work has the potential to significantly impact the treatment landscape for intraocular diseases.

Collaborations

Hui collaborates with talented individuals such as Yan Zhang and Lai Wei, who contribute to his research and development efforts. Their combined expertise enhances the potential for breakthroughs in the field.

Conclusion

Hui Ouyang's contributions to the treatment of intraocular diseases exemplify the importance of innovation in medical research. His patent and ongoing work at Smilebiotek Zhuhai Limited highlight his commitment to improving eye health and advancing therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…